Welcome to our dedicated page for Radnet news (Ticker: RDNT), a resource for investors and traders seeking the latest updates and insights on Radnet stock.
RadNet, Inc. (NASDAQ: RDNT) generates a steady flow of news as a national provider of freestanding, fixed-site diagnostic imaging services and as the parent of DeepHealth, its AI-powered health informatics division. News about RadNet often highlights developments across its network of 407 owned and/or operated outpatient imaging centers in markets such as Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas, as well as updates from its Digital Health segment.
Investors and observers following RDNT news will encounter announcements on topics such as acquisitions of imaging centers, expansion into new regional markets and updates on RadNet’s operational performance. For example, the company has reported acquisitions like Radiology Regional in Southwest Florida, adding multiple imaging centers and staff to its Florida footprint. Earnings releases and financial guidance updates are also frequent news items, reflecting trends in imaging volumes, segment revenue and Adjusted EBITDA for both the Imaging Center and Digital Health segments.
RadNet’s DeepHealth division is another major source of news, with press releases covering the launch of AI-powered clinical suites, imaging informatics platforms and collaborations with partners. Recent communications have described products such as Breast Suite, Thyroid Suite, Operations Suite, Diagnostic Suite and TechLive, as well as research findings published in scientific journals and showcased at industry conferences like RSNA. News may also cover strategic collaborations, including letters of intent and partnerships with companies such as GE HealthCare to expand AI-powered imaging solutions across modalities and geographies.
Because RadNet regularly issues updates on its financial results, acquisitions, digital health initiatives and research milestones, the RDNT news page can be a useful resource for tracking how the company’s imaging center operations and DeepHealth portfolio evolve over time. Readers interested in diagnostic imaging services, AI in radiology and healthcare operations technology may find RadNet’s news particularly relevant.
RadNet, a leader in outpatient diagnostic imaging, reported a 14.0% increase in revenue, totaling $332.7 million for Q3 2021, compared to Q3 2020. Adjusted EBITDA rose 36.0% to $62.3 million, reflecting strong operational performance despite challenges from hurricanes and COVID-19. Adjusted earnings per share improved to $0.21, up from $0.15 year-over-year. The company decreased its Net Leverage Ratio to 2.85x, the lowest in its history, prompting an increased guidance for 2021 on both Adjusted EBITDA and Free Cash Flow.
RadNet, Inc. (NASDAQ: RDNT) will host a conference call on November 8, 2021, at 7:30 a.m. PT to discuss its Q3 2021 financial results. Investors can listen by calling 888-394-8218 or 646-828-8193 for international access. A web broadcast will also be available. RadNet, a leading provider of diagnostic imaging services, operates 353 outpatient centers across various states including California and New York, employing approximately 8,300 personnel. For more details, visit RadNet's website.
RadNet, a leader in diagnostic imaging services, will have Mark Stolper, CFO, present at the 2021 LD Micro Main Event Conference on October 12, 2021, at 5:00 p.m. PT in Los Angeles. The event will also feature a pre-recorded presentation available on the Sequire Virtual Event Website. RadNet operates 353 outpatient imaging centers across several states including California and New York, employing around 8,300 staff. For additional information, visit RadNet's website.
RadNet, a leader in diagnostic imaging services, will have its CFO, Mark Stolper, present at the Sidoti & Company Fall 2021 Conference on September 23, 2021, at 4:00 p.m. Eastern Time. The event will feature a simultaneous webcast, providing accessibility for investors and stakeholders.
RadNet operates 353 outpatient imaging centers across the U.S., employing approximately 8,300 staff. For further details, the presentation can be accessed via this link or through their official website.
RadNet (RDNT) reported a robust second quarter of 2021, with revenue soaring 75.2% to a record $333.9 million, up from $190.6 million in Q2 2020. Adjusted EBITDA rose 150.7% to $56.6 million. The company also achieved an adjusted EPS of $0.27, contrasting with a loss of $(0.14) per share in the previous year. Total procedural volumes surged 92.7%, driven by significant increases in MRI and CT volumes. RadNet upgraded its 2021 guidance, anticipating higher revenue, adjusted EBITDA, and free cash flow, while preparing for potential impacts from COVID-19 variants.
RadNet, Inc. (NASDAQ: RDNT) will host a conference call on August 9, 2021, at 7:30 a.m. PT to discuss its Q2 2021 financial results. Investors can participate by calling 888-394-8218 or 646-828-8193 for international access, with webcasts available for listening. RadNet operates 346 outpatient imaging centers and employs approximately 8,300 people across several states. This conference call signifies the company's transparency and commitment to keeping investors informed about its financial performance.
RadNet, a leader in diagnostic imaging, announced that Greg Sorensen from its DeepHealth AI division will speak with Jefferies equity research analysts on June 30, 2021, at 1:00 p.m. ET. This call underscores RadNet's commitment to integrating artificial intelligence in its services. Interested participants can register for the live webcast or access the archived version via the provided link. RadNet operates 346 outpatient imaging centers across the U.S., employing about 8,300 staff in states including California and New York.
RadNet, a leader in diagnostic imaging services, announced that Mark Stolper, CFO, will present at the Jefferies 2021 Virtual Global Healthcare Conference on June 3, 2021, at 2:30 p.m. Eastern Time. The event will feature a webcast accessible at RadNet's website and through the Jefferies platform.
RadNet operates 346 outpatient imaging centers across several states, employing around 8,300 individuals. The company is recognized for its extensive market presence and annual imaging revenue in the U.S.
RadNet reported a 12% revenue increase to $315.3 million for Q1 2021 compared to Q1 2020. Adjusted EBITDA rose 123.4% to $45.5 million, while diluted net income per share improved to $0.18 from a loss of $(0.33) year-over-year. Procedural volumes grew 8.4% overall, with same-center volume increasing 5%. The company received FDA clearance for its DeepHealth AI mammography software and successfully refinanced its senior credit facilities, anticipating interest savings of up to $6 million. Full-year 2021 guidance was revised upwards for revenue, adjusted EBITDA, and free cash flow.
eRAD, a subsidiary of RadNet (NASDAQ: RDNT), announced the successful deployment of its Radiology Information System (RIS) by Shields Health Care Group across multiple imaging locations in New England. The collaboration enhances operational efficiency and patient experience through features like automated patient communication and digital forms for scheduling. Shields sought a flexible partner to accommodate diverse workflow needs, and the eRAD system aims to improve training for staff, allowing more focus on patient care. This implementation underscores eRAD's adaptability and commitment to advancing imaging services.
FAQ
What is the current stock price of Radnet (RDNT)?
What is the market cap of Radnet (RDNT)?
